SPRED2 and hyperlipidemia: In the present study, we explored the role of Spred2 in obesity and obesity-associated systemic responses, and found that Spred2 KO mice developed exacerbated obesity, hyperlipidemia, hyperglycemia, insulin resistance, and fatty liver upon feeding with HFD, reflecting a severe state of metabolic syndrome.